Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2023 Apr 18;329(15):1290-1295.
doi: 10.1001/jama.2023.4342.

Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force; Carol M Mangione  1 , Michael J Barry  2 , Wanda K Nicholson  3 , David Chelmow  4 , Tumaini Rucker Coker  5 , Esa M Davis  6 , Katrina E Donahue  7 , Carlos Roberto Jaén  8 , Martha Kubik  9 , Li Li  10 , Gbenga Ogedegbe  11 , Goutham Rao  12 , John M Ruiz  13 , James Stevermer  14 , Joel Tsevat  8 , Sandra Millon Underwood  15 , John B Wong  16
Affiliations
Practice Guideline

Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force et al. JAMA. .

Abstract

Importance: Skin cancer is the most commonly diagnosed cancer in the US. There are different types of skin cancer varying in disease incidence and severity. Basal and squamous cell carcinomas are the most common types of skin cancer but infrequently lead to death or substantial morbidity. Melanomas represent about 1% of skin cancer and cause the most skin cancer deaths. Melanoma is about 30 times more common in White persons than in Black persons. However, persons with darker skin color are often diagnosed at later stages, when skin cancer is more difficult to treat.

Objective: To update its 2016 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review on the benefits and harms of screening for skin cancer in asymptomatic adolescents and adults.

Population: Asymptomatic adolescents and adults who do not have a history of premalignant or malignant skin lesions.

Evidence assessment: The USPSTF concludes that the evidence is insufficient to determine the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in asymptomatic adolescents and adults.

Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults. (I statement).

PubMed Disclaimer

Summary for patients in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms